Share on StockTwits

Shares of BTG plc (LON:BTG) have received an average rating of “Hold” from the ten brokerages that are covering the company, Analyst Ratings Net reports. Three research analysts have rated the stock with a sell recommendation, one has assigned a hold recommendation and six have issued a buy recommendation on the company. The average 12-month target price among analysts that have covered the stock in the last year is GBX 566.25 ($9.50).

BTG plc (LON:BTG) opened at 608.50 on Wednesday. BTG plc has a 52-week low of GBX 363.00 and a 52-week high of GBX 665.00. The stock has a 50-day moving average of GBX 618.6 and a 200-day moving average of GBX 583.8. The company’s market cap is £2.196 billion.

A number of research firms have recently commented on BTG. Analysts at Deutsche Bank reiterated a “buy” rating on shares of BTG plc in a research note on Tuesday. They now have a GBX 655 ($10.99) price target on the stock. Separately, analysts at Jefferies Group upgraded shares of BTG plc to a “buy” rating in a research note on Tuesday, July 29th. They now have a GBX 760 ($12.75) price target on the stock, up previously from GBX 525 ($8.81).

BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology.

Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with Analyst Ratings Network's FREE daily email newsletter.